Table 1. Response of 222 Thai patients with various medical conditions to EuroQol 5D instrument, August to October 2009.
All (n = 222) | TBTX (n = 32) | MDRTX (n = 11) | anyTBC (n = 32) | anyHIV (n = 49) | TBTX/HIV (n = 49) | anyTBC/HIV (n = 49) | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Mobility | |||||||
No problem | 172 (77) | 21 (66) | 5 (45) | 28 (88) | 41 (84) | 32 (65) | 45 (92) |
Moderate problem | 50 (23) | 11 (34) | 6 (55) | 4 (12) | 8 (16) | 17 (35) | 4 (8) |
Severe problem | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Self care | |||||||
No problem | 210 (95) | 26 (81) | 9 (82) | 32 (100) | 48 (98) | 47 (96) | 48 (98) |
Moderate problem | 12 (5) | 6 (19) | 2 (18) | 0 (0) | 1 (2) | 2 (4) | 1 (2) |
Severe problem | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Usual activities | |||||||
No problem | 161 (73) | 22 (69) | 3 (27) | 29 (91) | 40 (82) | 26 (53) | 41 (84) |
Moderate problem | 57 (26) | 9 (28) | 6 (55) | 3 (9) | 9 (18) | 22 (45) | 8 (16) |
Severe problem | 4 (1.8) | 1 (3) | 2 (18) | 0 (0) | 0 (0) | 1 (2) | 0 (0) |
Pain/discomfort | |||||||
No problem | 95 (43) | 10 (31) | 0 (0) | 18 (56) | 23 (47) | 12 (24) | 32 (65) |
Moderate problem | 122 (55) | 21 (66) | 9 (82) | 14 (44) | 25 (51) | 36 (73) | 17 (35) |
Severe problem | 5 (2) | 1 (3) | 2 (18) | 0 (0) | 1 (2) | 1 (2) | 0 (0) |
Anxiety/depression | |||||||
No problem | 125 (56) | 15 (47) | 3 (27) | 25 (78) | 27 (55) | 23 (47) | 32 (65) |
Moderate problem | 93 (42) | 17 (53) | 7 (64) | 7 (22) | 20 (41) | 26 (53) | 16 (33) |
Severe problem | 4 (2) | 0 (0) | 1 (9) | 0 (0) | 2 (4) | 0 (0) | 1 (2) |
TBTX, TB patients receiving TB treatment; MDRTX, MDR-TB patients receiving MDR-TB treatment; anyTBC, patients who had been successfully treated for TB or MDR-TB for ≥6 months; anyHIV, HIV-infected patients at any stage; TBTX/HIV, HIV-infected TB patients receiving TB treatment; anyTBC/HIV, HIV-infected patients who had been successfully treated for TB or MDR-TB for ≥6 months.